VKH
ABMD

Virtu KCG Holdings’s Abiomed Inc ABMD Stock Holding History

Virtu KCG Holdings’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-4,845
Closed -$607K – 3648
2017
Q1 		$607K Buy
4,845
+1,316
+37% +$153K 0.02% 1176
2016
Q4 		$398K Sell
3,529
-982
-22% -$114K 0.01% 1778
2016
Q3 		$580K Sell
4,511
-15,522
-77% -$1.86M 0.01% 1225
2016
Q2 		$2.19M Buy
+20,033
New +$1.99M 0.05% 303
2015
Q4 		– Sell
-2,434
Closed -$226K – 4056
2015
Q3 		$226K Buy
+2,434
New +$214K ﹤0.01% 2436

Other funds holding ABMD

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Virtu KCG Holdings's ABMD Position: Q2 2017 in Review

Virtu KCG Holdings sold out of Abiomed Inc (ABMD) in Q2 2017, closing a stake of 4,845 shares — an estimated $607K sold.

Virtu KCG Holdings first reported a position in ABMD in Q3 2015 and held it in 5 quarters. The position peaked at $2.19M in Q2 2016. 303 funds tracked by Wall St. Rank hold ABMD as of Q2 2017.

  • Virtu KCG Holdings reported no remaining Abiomed Inc position as of Q2 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 4,845 Abiomed Inc shares in Q2 2017, an estimated $607K.
  • Virtu KCG Holdings first reported a position in Abiomed Inc in Q3 2015 and held it in 5 quarters.
  • Virtu KCG Holdings's Abiomed Inc position peaked at $2.19M in Q2 2016.
  • 303 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.